Showing results (1781-1790 of 14,093) with videos related to
Sort By:
Pageof 1,410
Gynecologic Oncology|August 1, 1990
Primary paraovarian cystadenocarcinoma: clinical and management aspects and literature reviewM M Altaras, R Jaffe, M Corduba, et al.Gynecologic Oncology|November 1, 2011
HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3L Baandrup, C Munk, K K Andersen, et al.Gynecologic Oncology|October 20, 2011
Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancerKeiichiro Nakamura, Noriaki Imafuku, Takeshi Nishida, et al.Gynecologic Oncology|October 22, 2011
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag levelYoo-Young Lee, Chel Hun Choi, Chang Ohk Sung, et al.Gynecologic Oncology|October 29, 2011
The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterationsPeter Svenssen Munksgaard, Jan BlaakaerGynecologic Oncology|October 28, 2011
Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancerSaketh R Guntupalli, Israel Zighelboim, Nora T Kizer, et al.Gynecologic Oncology|September 10, 2011
Independent external validation of radiotherapy and its impact on the accuracy of a nomogram for predicting survival of women with endometrial cancerMartin Koskas, Sofiane Bendifallah, Dominique Luton, et al.Gynecologic Oncology|September 13, 2011
Outcome in early cervical cancer following pre-operative low dose rate brachytherapy: a ten-year follow up of 257 patients treated at a single institutionC Ngô, S Alran, C Plancher, et al.Gynecologic Oncology|September 13, 2011
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experienceAndrea Maneo, Mario Sideri, Giovanni Scambia, et al.Gynecologic Oncology|June 1, 1990
Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?B Patsner, J W Orr, W J Mann, et al.Pageof 1,410